FDA Solicits Protocol For Assessing Cosmetic Ingredient Aggregate Exposure Risks
Executive Summary
According to its May 16 notice, the agency intends to award the contract to NSF International. An FDA spokesperson said NSF already undertook related work for the agency in 2018 and has rendered similar services for the US Environmental Protection Agency.
You may also be interested in...
US FDA Focused On Vulnerable Populations As Cosmetic Risk Assessment Protocol Develops
The agency’s recent request for contractor quotes cites infants and children, people of color, and immunosuppressed individuals among users whose “unique biological characteristics” could require special consideration in the evaluation of cosmetic ingredients. The FDA also is interested in accounting for unique physicochemical aspects of ingredients such as engineered nanomaterials.
US FDA’s Cosmetics Director Katz Cites Fragrance Allergens, Talc-Containing Products Among Priorities
Linda Katz, director of the US FDA’s Office of Cosmetics and Colors, offered insight into priority cosmetics issues at the Independent Beauty Association’s virtual FDA Cosmetic Regulations Workshop.
Tattoo Ink Manufacturers Warned About Microbial Contamination After Recalls
FDA sends warning letters to two Florida tattoo ink firms linked to a safety alert and recall in May and a New Jersey tattoo ink company for contamination in products that require the firms to quickly correct deficiencies that are a ‘significant’ health and regulatory concern.